+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lateral Flow Assays - Global Market Trajectory & Analytics

  • ID: 4805627
  • Report
  • May 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • MORE

Global Lateral Flow Assays Market to Reach US$11.6 Billion by the Year 2027


Amid the COVID-19 crisis, the global market for Lateral Flow Assays estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$11.6 Billion by 2027, growing at a CAGR of 5.9% over the period 2020-2027.Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lateral Flow Readers segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 17.9% share of the global Lateral Flow Assays market.



The U.S. Accounts for Over 38.6% of Global Market Size in 2020, While China is Forecast to Grow at a 8.8% CAGR for the Period of 2020-2027


The Lateral Flow Assays market in the U.S. is estimated at US$3 Billion in the year 2020. The country currently accounts for a 38.64% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$917 Million in the year 2027 trailing a CAGR of 8.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$917 Million by the year 2027.

Select Competitors (Total 55 Featured) -

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Johnson & Johnson
  • PerkinElmer, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • MORE
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
  • Impact of COVID-19 on Lateral Flow Assays Market
  • Performance Analysis of COVID-19 Tests
  • EXHIBIT 2: COVID-19 Cases Worldwide by Country: As on May 17, 2021
  • Lateral Flow Assay-based Tests Soar into Spotlight during COVID-19 Pandemic
  • LFAS Arms Nations to Battle the Coronavirus
  • GLOBAL MARKET OVERVIEW
  • A Prelude to Lateral Flow Technology
  • Lateral Flow Assays: An Introduction
  • Lateral Flow Assays: A Mighty, Paper-based Diagnostics Approach
  • Lateral Flow Assays Market Poised to Experience Uninterrupted Flow Ahead
  • Clinical Testing Remains Primary Application Segment of Lateral Flow Assays Market
  • Rising Incidence of Infectious Conditions Ignite Demand
  • LFA Overcomes Testing Barriers
  • The US Retains Leadership Tag in Global Lateral Flow Assays Market
  • Fast Paced Growth Projected in Developing Regions
  • Market Outlook
  • Competitive Scenario
  • RECENT MARKET ACTIVITY
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Growing Incidence of Infectious Diseases to Drive LFA Market
  • EXHIBIT 3: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • EXHIBIT 4: Global Malaria Case Incidence Rate (per 1,000 population) for the Years 2015, 2016, 2017 & 2018
  • EXHIBIT 5: Global TB Cases (In Millions) Reported to Have Been Treated for the Years 2015-2019
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • EXHIBIT 6: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • EXHIBIT 7: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Home HIV Testing Emerges as a Lucrative Option
  • Viral Hepatitis Testing Presents Opportunities for Lateral Flow Assays Market
  • EXHIBIT 8: Hepatitis B prevalence Worldwide by Region
  • Uptrend in Healthcare Spending Creates Fertile Environment
  • EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • EXHIBIT 10: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Ageing Demographics to Drive Demand
  • EXHIBIT 11: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • EXHIBIT 12: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Self-Diagnosis Emerges as a Notable Trend
  • New Approvals of Self-Test Devices to Give a Boost to the Market
  • Lateral Flow Assays Hold Rosy Outlook with Emerging Applications Areas
  • LFAs Gains Foothold in Multiplexing
  • Multiplexed Point-Of-Care Testing
  • Remote Healthcare Benefits Lateral Flow Assays Market
  • Lateral Flow Assays to Become Landmark Approach in Precision Diagnostics
  • Lateral Flow Assays & Precision Diagnostics
  • Digitalization of Lateral Flows to Support Healthcare
  • Digitalized Lateral Flow Assays: An Exciting Platform to Change Data-Driven Healthcare Domain
  • Lateral Flow Assays Emerge as Integral Components of Food Safety & Environmental Testing
  • Novel Lateral Flow Assay Marks Shift from Reactive to Proactive Food Safety Testing Approach
  • Technological Advancements Remain Crucial to Future Growth
  • Researchers Develop Novel Technique to Significantly Increase Accuracy of Lateral Flow Tests
  • Smartphone-based Fully-Quantitative Lateral Flow Assay Analyzer for Reliable & Quick Diagnosis
  • Innovative Lateral Flow Immunoassays Find Increasing Role in Detection of Dengue & Zika Virus
  • Abingdon Health Introduced ADxLR5® Developer for Assay Development
  • Rapid Tests Connectivity with Wireless Data Platforms
  • Miniaturization of Analytical Instruments Presents Lucrative Opportunities for Handheld Lateral Flow Assay Readers
  • Low Accuracy Remains a Major Restraint
  • Limited Reimbursement & Raw Material Supply Issues as Key Challenges
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES

CANADA

JAPAN

CHINA

EUROPE

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 55

Note: Product cover images may vary from those shown
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Johnson & Johnson
  • PerkinElmer, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll